RBP4 has been previously related to insulin resistance and clinical markers of increased cardiovascular risk such as intima-media thickness (IMT), not only in high-risk individuals including hypertensive and type 2 diabetic and hypertensive patients[10,12], but also in the general population[23]. Here, RBP4 is linked to Insulin resistance.